Status:
COMPLETED
Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause
Lead Sponsor:
University Hospital of North Norway
Collaborating Sponsors:
University of Tromso
The International Osteoporosis Foundation
Conditions:
Perimenopausal Bone Loss
Eligibility:
FEMALE
50-60 years
Phase:
PHASE2
Brief Summary
Study Objective: To determine whether Natto supplementation in women immediately after menopause might prevent severe bone loss Study population: Women 50 - 60 years, 1-5 years after menopause Study...
Eligibility Criteria
Inclusion
- Women living in the city of Tromsø, not using hormone replacement therapy, 1-5 years after menopause.
Exclusion
- History of hip fracture
- Bone disease affecting bone mineral density
- Use of vitamin K antagonists
- Significant co-morbidity that makes it difficult to obtain BMD measurements
- Use of hormone replacement therapy or other therapy that influence bone remodeling
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
304 Patients enrolled
Trial Details
Trial ID
NCT00290212
Start Date
January 1 2006
End Date
June 1 2007
Last Update
January 24 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Center, University Hospital of North Norway
Tromsø, Tromsø, Norway, N-9038
2
Haukeland University Hospital
Bergen, Norway, NO 5021